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A  large body of experimental data indicates that T  cell growth factor, inter- 
leukin 2 (IL-2), j participates in a number of in vitro assays for immune responses. 
For  example,  IL-2  has  been  shown  to  maintain  the  in  vitro  proliferation  of 
antigen-specific,  cytolytic, and  helper  T  cell  lines  (1,  2);  to  contribute  to  the 
formation of cytotoxic T  lymphocytes in cultures stimulated with alloantigen (3); 
to enhance thymocyte mitogenesis, and to mediate the development of erythro- 
cyte-specific antibody-producing cells in  T  cell-deficient cultures (4-6).  Based 
on these activities in  vitro it seems likely that  IL-2 will also play a  role in cell- 
mediated immunity in vivo. 
Tests  for the  in  vivo relevance of IL-2  would  be  greatly  facilitated  by  the 
development of specific reagents that could detect the molecule independent of 
its  biological activity, or  block  its  action,  or  both.  Specific antibodies  to  IL-2 
might be expected to have such properties; in addition, they could be valuable 
specific  immunoadsorbents  in  IL-2  purification  and  characterization,  and  in 
studies of IL-2 biosynthesis. With this in mind, we have raised antibody in rabbits 
using as antigen a  highly purified fraction of mouse IL-2 whose isolation from 
spleen cell cultures we have recently described (7). The characterization of these 
anti-IL-2 antibodies, and some of their effects in vitro and in vivo, are reported 
here. 
Materials and Methods 
Male BALB/c, C57bl/6 and athymic (nude) BALB/c mice were obtained from Charles 
River Breeding  Laboratories,  Inc.,  Wilmington,  MA.  [SH]Thymidine (sp  act  17.5  Ci/ 
mM), [35S]methionine  (sp act 1,000 Ci/mM) and 51Cr (sp act 331 mCi/mg) were purchased 
from  Schwarz/Mann  Div.,  Becton  Dickinson  and  Co.,  Orangeburg,  NY;  Dulbecco's 
minimal essential medium (MEM) and fetal bovine serum from Grand Island Biological 
Co., Grand Island, NY; acrylamide, bis-acrylamide, N,N',N'N'-tetramethylethylene-dia- 
mine, and ammonium persulfate from Eastman Kodak Co., Rochester, NY; three times 
crystallized concanavalin A (Con A) from Miles Laboratories, Inc., Elkhart, IN. Protein 
A-Sepharose and activated CNBr-Sepharose were obtained from Pharmacia Fine Chemi- 
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cals, Piscataway, N  J; trasylol, bovine serum albumin (BSA),  a-phorbol  12-myristate 13- 
acetate (PMA) from Sigma Chemical Co. (St.  Louis,  MO); oligo (dT) cellulose type 77 
from PL Biochemicals; tissue culture plasticware from Falcon  Labware Div. of Becton, 
Dickinson and Co., Oxnard, CA. Alu Gel S (2% suspension) from Accurate Chemical and 
Scientific  Corp.,  Westbury,  NY.  All  reagents  were of the  highest  grade commercially 
available. 
Antibody Production.  Antibodies to IL-2 were raised in rabbits. Purified IL-2 fraction 
VI (7) (1-10 #g) was mixed  I:1 with Alu Gel and injected intradermaUy on the back of 
the animal in  30 different sites.  Identical booster injections were administered every 4 
wk. Antibody responses were detectable 2-3 months after the first injection. 
Mixed Leukocytic Reaction (MLR).  The effect of anti-IL-2 on antigen-induced  T  cell 
proliferation was tested in primary MLR using replicate 100 #1 cultures (MEM, 5% heat- 
inactivated fetal calf serum (FCS), 5 ×  10  -s M 2-mercaptoethanol, and antibiotics) of 1 × 
106 cells/ml C57B1]6  responder spleen cells and  1.5  ×  106 cells/mi BALB/c irradiated 
(1,000  rad) splenic stimulator cells.  Replicate cultures were supplemented with varying 
concentrations of either anti-IL-2 Ig or preimmune Ig. After 5 d  of culture (37°C in a 
humidified atmosphere of 10% CO2, 7% 02, and 83% nitrogen), cells were exposed to a 
4-h pulse of 1.7  #Ci [3H] TdR. The cultures were then collected onto glass fiber strips 
using a  Brandeil cell harvester and  [SH] TdR incorporation was determined  by liquid 
scintillation counting in liquifluor toluene.  For CTL response viable effector cells were 
tested for their ability to lyse 5|Cr-labeled allogeneic P815 target cells. 
Preparation  of Conditioned Medium Rich in IL-2.  Conditioned  medium from Con A- 
activated spleen  cells were prepared as described  elsewhere (7).  Conditioned  medium 
from blast cells was prepared by plating 2 x  106 3-d Con A-stimulated spleen cells in 35- 
mm cultures in  1 ml of MEM medium containing 5 x  10  -5 M 2-mercaptoethanol, and 5 
#g/ml Con A. After 2 h the Con A-induced cell monolayers were washed to remove Con 
A and the medium replenished with 2 ml of MEM plus 5 x  10 -5 M 2-mercaptoethanol. 
Cell-free supernatant media were harvested at the desired time, centrifuged to remove 
cell debris, and stored at -20°C. 
Assay for T Helper Activity.  Antibody synthesis was measured as described by Mishell 
and  Dutton  (8).  Spleen  cells  from BALB/c,  BALB/c  nu/nu,  and  C57bl]6  mice  were 
resuspended in  MEM supplemented with 5%  FCS to a density of 5  X  108 cells/ml and 
distributed into 35-mm plates; 50 ~1 of 0.5%  sheep erythrocytes (SRBC) were added as 
antigen  to each culture.  Immune or preimmune Ig or IL-2 were added at the desired 
concentration on day 0 or day 2. The culture was incubated with gentle rocking for 5 d 
and the cells were harvested and assayed for the antibody production in the Jerne plaque 
assay as modified by Mishell and Dutton (8). The results are expressed as the number of 
lytic plaques formed by 106 cells. 
Assay  for IL-2.  IL-2 activity in conditioned media was assayed on 3 d Con A-stimulated 
spleen cells as described previously (7).  1 U  was defined as the amount of IL-2 required 
to double the [SH]-TdR incorporation observed in untreated cultures. Con A supernatants 
(containing ~ 10 U/ml of IL-2) were incubated for 2 h with or without serial dilutions of 
anti-IL-2 or preimmune serum and then mixed with T  cell blasts (4 x  105 cells]ml). 20 h 
after culture initiation cells were exposed to a pulse of [SH]-TdR for 4 h. 
IL-I Assay.  IL-1  was assayed for its ability to stimulate the proliferative response of 
C3H/HJ thymocytes to phytohemagglutinin (PHA). Several dilutions of IL-l-containing 
supernatants produced by the J7774 macrophage cell line stimulated with lipopolysaccha- 
ride,  were  dispersed  to  individual  microculture  wells  in  100  #l  and  then  100  #!  of 
thymocytes suspension (1.5 x  107/ml) was added to each well. After 72 h cells were pulsed 
for 4 h with [SH]-TdR. 
IL-3 Assay.  A  FDC/D~ cell line, described by Ihle (9) was used as the responding cell 
in a proliferative assay. 2 x  104 cells were cultured in microwells with several dilutions of 
supernatants from the WEHI-3 cell line and the response was measured after 20 h  by 
[SH] TdR incorporation (4 h). 
Interferon Assay.  Con A supernatants were titrated for their inhibition of the cytopathic 
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were seeded in microtest wells with threefold dilutions of supernatant or fractions to be 
assayed. After 20 h of incubation an infecting dose of vesicular stomatitis virus was added. 
The  plates  were  examined  under  the  microscope  to  determine  the  last  dilution  of 
supernatant that inhibits the lysis of one-half the cells. 
B Cell Stimulating Factor Assay.  Assay for B cell helper factors was done as described 
by Inaba et al. (10) using 3 x  10  ~ purified B cells as responder and SRBC as antigen. The 
development of anti-sheep plaque-forming cells (PFC) requires helper factors and antigen 
and is antigen specific (10). 
Cytotoxic Differentiation  Factor.  Assay for factors necessary for the  development of 
cytolytic T  cells was performed according to Granelli-Piperno and Steinman (manuscript 
in preparation). 5 x  105 thymocytes from Swiss mice (4 wk old) were suspended in MEM 
medium supplemented with  10% heat-inactivated FCS,  5  x  10 -5 M B-mercaptoethanol, 
and  1 #g/ml  Con  A,  and cultured  in  microwells with  several dilutions  of conditioned 
media. Polyclonal cytolytic T  lymphocyte (CTL) response was measured after 72 h using 
5'Cr-labeled P815  as  targets  in  the  presence  of  10  #g/ml  PHA.  Addition  to  the  cell 
cultures of purified or recombinant IL2 (Biogen), -/-IFN (Genentech), or IL-1 only did 
not support CTL response in this assay. 
Polyacrylamide Gel Electrophoresis (SDS-PAGE).  SDS-PAGE was performed as described 
by Laemmli (11).  Conditioned medium was concentrated 10-fold over an Amicon PM-10 
membrane. Samples were then  mixed with an equal volume of double-strength sample 
buffer and electrophoresed in a  12.5% polyacrylamide slab gel. One lane of the gel was 
cut  into  1-mm slices,  eluted  in  phosphate-buffered saline  (PBS)  for  18 h  at  4°C,  and 
assayed for IL-2 activity. Protein bands were visualized by silver staining techniques (12). 
Anti-lL-2 Affinity Chromatography.  Serum from immunized rabbits was diluted 1:1 with 
PBS and loaded onto a protein A-Sepharose column. The column was washed with PBS 
containing 0.4  M NaCI and the Ig fraction was eluted with 0.1  M glycine HCI, pH 2.3 
and immediately neutralized with  1 M Tris. Immunoglobulin G (7.5 mg) was extensively 
dialyzed against coupling buffer (0.05  M  MES,  pH 6.5),  coupled to  1.5  ml of swollen 
activated C NBr Sepharose, and the mixture shaken for 12-15 h at 4 o  C. Residual activated 
groups were quenched by incubating the resin for 2 h in 1 M Tris/HC1 pH 9. Unmodified 
conditioned medium containing IL-2 activity was passed through the column at neutral 
pH, the resin was washed with 70 ml of PBS containing 0.4 M NaCi,  1% Triton X-100, 
0.2% SDS,  1 mM EDTA followed by 50 ml of PBS, and IL-2 was then eluted with 0.1  M 
glycine HCI, pH 2.3. 
Immune Precipitation of  Biosynthetically Labeled IL-2.  2 ×  107 spleen cells were incubated 
for 2 h  with  Con  A  (5  •g/ml)  in  serum-free medium, and  the  supernatant  removed; 
methionine-deficient Dulbecco's medium containing 1/20th of the usual level of methio- 
nine and 50 #Ci/ml [35S]methionine was added and incubation continued for a  further 
20 h. Immunoprecipitation was then performed as follows: culture medium was made 1% 
in SDS and boiled for 5 min, after which Triton X-100 was added to a final concentration 
of 5%. The samples were immunoprecipitated for 16 h at 4°C, protein A-Sepharose was 
added, the mixture incubated for 30 min at room temperature and then centrifuged.The 
pellets were washed three times with NETTS buffer (0.5 M NaC1, 0.2% SDS,  1% Triton 
X-100,  1 mM EDTA, 50 mM Tris HCI, pH 7.4) and once with 0.5 M NaCI, 0.1% SDS, 
50 mM Tris HCI, pH 7.4.  Proteins were eluted by boiling the pellets in electrophoresis 
sample buffer andapplied to 12.5% SDS-PAGE. 
Popliteal Lymph Node Assay.  The popliteal lymph node response to antigen stimulation 
6  was measured according to Lafferty et al. (13).  30 #1 of PBS containing 3 ×  10  C57BL/ 
b  d  6J (H-2) spleen cells were injected into the left hind footpad of BALB/c (H-2) recipients. 
As control, the right hind footpads were injected with 30 #1 of PBS alone. The animals 
were then  either given daily  intravenous injections of anti-IL-2 IgG (0.4  mg/d) or an 
equivalent  dose  of preimmune  IgG, or  were  left uninjected.  After  2,  3,  and  4  d  the 
draining popliteal lymph nodes were removed and assayed for cytotoxic activity against 
EL-4  (H-2  b)  targets.  Results  are  expressed  as  log  10  cytotoxic units  (C-U)  per  node 
according to Lafferty et al. (13). 
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Lizardi and Engelberg (14). For the preparation of RNA from EL-4 culture cells (5 x  105 
cells/ml) were stimulated for 5 h with PMA (10 ng/ml) and Con A (5 #g]ml), collected by 
centrifugation, washed twice with PBS, and lysed with buffer A (25 mM Tris/HCl, pH 
7.4,  0.1  M  NaCI,  7.5  mM  EDTA,  25  mg/ml  polyvinyl sulfate,  2.4%  SDS  350  #g/ml 
proteinase K; 3  ml for 1 ×  108 cells) at 37°C for  15 min; then 2/3 volume of 3.5 M 
NaCIO4  was  added and  the  viscosity of the  solution  was  reduced by passing  it twice 
through a 21-gauge needle, after which nucleic acids were precipitated with 4 vol of EPR 
(NaCIO4  saturated  ethanol/water,  4:1)  kept  at  4°C  for  60  min,  and  the  precipitate 
collected by centrifugation at 6,000 rpm. The pellet was dissolved in buffer B (25 mM 
Tris/HC1, pH 7.4,  1 mM EDTA, 0.2% SDS; 8 ml for 1 ×  108 cells), NaCl, was adjusted 
to  0.2  M,  0.6  vol  of isopropanol was  added,  and  the  solution  was  stored at  -20°C 
overnight. The precipitate was collected by centrifugation, the pellet resuspended in H20, 
0.2  M  NaCI added, and  nucleic acids reprecipitated with  2.5  volumes of ethanol and 
stored at -20 °C overnight. The precipitate was collected as above and the pellet dissolved 
in  H~O  to a  concentration of 20  OD2n0 U/ml.  Lithium dodecyl sulfate was  added to 
0.07 %, LiCI was added to 0.2 M, and the solution was left at 4 °C for 4 h. The precipitated 
RNA was collected by centrifugation and reprecipitated twice with ethanol and salt.  For 
the preparation of control RNA,  cells  were lysed in  buffer A  immediately before the 
addition of PMA and Con A and processed in the same way. 
The preparation of poly A ÷ RNA was accomplished by batchwise fractionation using 
oligo (dT) cellulose. RNA was dissolved in H~O to 100 OD~60 U/ml, heated at 60°C for 
2 min, cooled quickly, an equal volume of 2 ×  HSB-buffer (HSB; 10 mM Tris/HCi, pH 
7.4, 0.12 M NaCI,  1 mM EDTA, 0.20% SDS) and prewashed oligo (dT) cellulose (1 mg 
cellulose for 1 OD260 units) was added.  After the solution was shaken for 1 h  at room 
temperature, the resin was washed 6 times with HSB, twice with HSB minus SDS, then 
poly A ÷ RNA was eluted with H,O three times. For each wash the resin was collected by 
centrifugation at 3,000 rpm for 3 min. The eluate was precipitated with 3 vol of ethanol 
after adjusting 0.3  M  NaCI, and the sedimented RNA dissolved in H20 and stored at 
-80°C. From 5 ×  l0  s cells  150 ~g of poly A  + RNA was obtained. 
Microinjection of  Oocytes.  40 ng ofpoly A ÷ RNA were injected in Xenopus laevis  oocytes. 
Groups of 20 injected oocytes were incubated in microwells containing 200 ~1 of Barth's 
incubation medium (15) supplemented with BSA (0.5 mg/ml) and Trasylol (50 U/ml). 
After  20 h  the  medium  was  collected and  centrifuged  for  5  min  at  12,000 g  in  an 
Eppendorf microcentrifuge, and aliquots of supernatants were assayed for IL-2 activity. 
Results 
To characterize the anti-IL-2 antibodies,  the properties of either unfraction- 
ated antisera or purified immunoglobulins were evaluated in a series of biochem- 
ical and biological tests. 
Inhibition of  lL-2-dependent Lyraphoblast Proliferation.  Antibodies in rabbit sera 
were  initially  detected  by  an  IL-2  neutralization  test  in  which  the  antibody 
blocked the proliferation of T  lymphoblasts mediated by the conditioned medium 
from Con A-stimulated spleen cell cultures. The action of one pool of antisera 
is shown in Fig. 1, where it can be seen that immune serum completely suppressed 
the growth-promoting action of conditioned medium, while the same amount of 
preimmune rabbit serum was inert. Identical results (not shown) were obtained 
with  the  respective immunopurified immunogtobulin  at final concentration of 
5-10 t~g/ml. 
The specificity of this inhibition for IL-2 was established by the failure of the 
antisera to block the action of other lymphokines, including v-interferon, IL-3 
(Table I), and B cell stimulating factor (10). 
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FIGURr  1.  Inhibition of IL-2 activity in conditioned medium from Con A-stimulated spleen 
cells. Aliquots of conditioned medium were incubated for 2 h with serial dilution of preimmune 
(O) or anti-IL-2 antiserum (0) and then mixed with T  cell blasts; after 20 h of incubation the 
cultures were exposed to a 4-h pulse of [SH]-TdR. Results are expressed as percentage of IL- 
2 activity inhibited by antibodies. 
TABLE  I 
Specificity of a-IL-2 Neutralization Assay 
Lympho-  Source of 
kine  Factor 
Preimmune IgG added  a-IL-2 IgG added 
50  25  12.5  50  25  12.5 
#g/ml  ~g/ml 
IL-2*  Con A sup  127,000  125,000  129,000  1,450  1,630  1,890 
IL-3*  WEHI-3 sup  97,000  107,100  103,000  115,950  98,800  111,400 
IFN  ~  Con A sup  300  300  300  300  300  300 
Aliquots of conditioned media were preincubated with antibody for 2 h at 37 °C and then assayed 
for lymphokine activity. 
*~; Results are expressed as [3H]-TdR cpm incorporated. 
! Results are expressed as interferon units. 
action of antisera prompted us to test whether they could be used to precipitate 
biosynthetically radiolabeled lymphokine. The supernatant of mouse spleen cells 
cultures  stimulated  by addition  of Con  A  and  incubated  for  20 h  with  [aSS]- 
methionine were immunoprecipitated with purified anti-IL-2 IgG and the washed 
precipitate was analyzed by SDS-PAGE. The autoradiogram in Fig. 2 shows that 
the immune IgG precipitate  (but not that from preimmune IgG) contained a 
radioactive  protein  whose  mobility yielded an  apparent  Mr of 23,000,  which 
corresponds exactly with the migration of active IL-2 under the same conditions 
(7).  Taken  together with the preceding results,  this finding indicates that  the 
antibodies both neutralize IL-2 activity and precipitate the lymphokine. 
Neutralization  of Oocyte-translated  IL-2.  As  a  basis  both  for  exploring  the GRANELLI-PIPERNO  ET  AL.  743 
FIGURE 2.  Immunoprecipitation of biosynthetically  labeled IL-2. Autoradiogram of labeled 
proteins remaining in supernatant after IL-2 precipitation with preimmune Ig (lane A), or 
anti-IL-2 Ig (lane B); immunoprecipitate obtained with preimmune IL-2 Ig (lane C) or anti-IL- 
2 Ig (lane D). 
TABLE II 
Inhibition by Anti-IL-2 of IL-2 Activity Produced by Microinjected 
Xenopus Oocytes 
[SH]-TdR cpm 
Source of mRNA 
-a-IL-2  +a-IL-2 
None  1,020 _+ 15  NT 
EL-4  1,170 + 12  1,050_+ 9 
EL-4 stimulated  15,310 _  114  1,370 _+ 7 
Conditioned medium from injected Xenopus oocytes (see Materials and 
Methods) was incubated for 2 h with or without anti-IL-2 IgG (5/~g/ml) 
and then mixed with T cell blasts. 20 h after cultures initiation cells were 
pulsed for 4 h with [SH]-TdR. 
feasibility of cloning mouse IL-2 gene, and for characterizing the nature of IL-2 
activity synthesized in heterologous translation systems, we assayed the effect of 
anti-IL-2 on incubation  medium  from cultured Xenopus  laevis oocytes that had 
been  injected  with  mRNA  preparations  extracted from an  IL-2-producing T 
cell  line  (EL-4).  In  this  experiment  poly  A ÷  RNA  was  extracted  from  EL-4 
cultures 5 h after IL-2 production was stimulated by addition of PMA. Following 
purification and isolation of mRNA (see Materials and Methods) Xenopus oocytes 
were microinjected with 40 ng of RNA from either PMA-stimulated or unstim- 
ulated  cultures.  After  24 h  of incubation  the  oocyte incubation  medium  was 
assayed  for  IL-2  activity  (Table  II).  IL-2  activity  was  detectable  only  in  the 
medium  conditioned by oocytes that  had  received poly A +  RNA  from  PMA- 
treated cultures,  and  the  IL-2  was  completely neutralized by the anti-IL-2  Ig. 
This result demonstrates the faithful translation of IL-2 mRNA in oocytes and 
the immunological cross-reaction of the product with lymphokine purified from 
spleen cell culture medium. 
Antibodies Neutralize  the Activity of Two Forms of lL-2.  The major species of 
IL-2 present in spleen cell conditioned medium, which after purification, served 744  EFFECT OF  ANTI-IL-2 ON  IMMUNE RESPONSES 
as immunizing antigen for raising  the antisera  used in  this study, migrates  in 
SDS-PAGE under nonreducing conditions with apparent Mr 23,000 (7). 
While exploring the responses of other mouse lymphoid cell populations, we 
observed that lymphoblasts upon stimulation with Con A released an IL-2 whose 
rate of migration in  SDS-PAGE  corresponded  to Mr  20,000.  This  component 
was  clearly  separated  from  the  23-kdalton  protein  both  during  initial  and 
subsequent  electrophoresis.  Although the  significance of the  lower  molecular 
weight  form  has  not  been  defined,  we  found  that  its  mitogenic  action  on 
lymphoblasts is just as sensitive to inhibition by antibody as is that of the slower 
moving species. This suggests that the two are closely related, the electrophoretic 
difference possibly being due to differences in glycosylation  or limited proteolysis. 
Molecular heterogeneity of IL-2 observed here is not unique because human IL- 
2  (16)  and other cytokines, such as GM-CSF (17),  have been shown to exhibit 
different molecular  characteristics  dependent  on  the  experimental  conditions 
used. 
Immunoaffinity Purification  oflL-2.  The anti-IL-2 immunoglobulins could be 
used for construction of affinity columns that effectively retained IL-2 activity. 
When IL-2 fractions, concentrated and slightly purified by chromatography on 
hydroxylapatite columns (7),  were passed through such an affinity column the 
IL-2 activity was retained and could be recovered in good yield (20-50%)  in the 
usual dissociating buffer (0.1  M  glycine HCI,  pH  2.3)  (Table  III,  Fig.  3).  The 
23-kdalton component in these eluates, though highly purified, was contaminated 
TABLE  III 
Purification  of Mouse IL-2 Using Mouse Anti-lL-2 Sepharose 
Fraction  Volume  Total pro-  Total  Sp act  Yield 
tein  units 
ral  mg  U  U/rag  % 
Con A supernatant  800  24  550  23  100 
Hydroxylapatite  30  6.3  386  61  60 
Anti-IL-2 Sepharose  9  0.00135  120  88,888  21.8 
For determination of protein recovered in each fraction, BSA was used as a 
standard in the Bio-Rad  assay. 
FIGURE 3.  SDS-PAGE  of hydroxylapatite  and anti-IL-2  Sepharose  purified IL-2. The protein 
bands were visualized by silver staining. (a) Standard protein: bovine serum albumin (Mr 
68,000), ovalbumin  (Mr 43,000), carbonic anhydrase (Mr 30,000) and soybean  trypsin inhibitor 
(Mr 20,000). (b) Hydroxylapatite  purified IL-2. (c) Anti-IL-2 purified IL-2. GRANELLI-PIPERNO  ET  AL.  745 
with  two other  major  proteins  that  gave  bands  corresponding  to Mr  of 60- 
65,000 and 90-100,000.  However, mitogenicity for lymphoblasts was associated 
entirely with the 23-kdalton species. We note that IL-2 activity was unstable after 
immunoaffinity purification, with 50% loss of activity occurring within 15 d, at 
either acid or neutral pH, and at either 4°C or -20°C.  If these fractions were 
further purified by SDS-PAGE,  the resultant preparation were stable,  without 
detectable loss of activity, for at least 10 months at 4 °C. Human IL-2 could not 
be adsorbed onto anti-mouse IL-2 column, consistent with the known antigenic 
differences between the two species (18). 
Interaction of Antibodies with IL-2 and Not with Other Lymphokines.  Anti-IL-2 
antibodies do not neutralize or absorb other soluble mediators; Table IV shows 
the specificity of the anti-IL-2 Ig Sepharose column. Various cell culture super- 
natants  were fractionated  on anti-IL-2  Ig Sepharose and unbound and eluted 
fractions assayed for the specific lymphokines. The results clearly show that the 
anti-IL-2  Sepharose  column  absorbed  and  purified  only  IL-2.  All  the  other 
iymphokines testedwlL-1,  IL-3, ~-IFN, B cell stimulating factor, and cytotoxic 
differentiation factor--were found in the unbound fractions. 
Biological Effects of Anti-IL-2 Antibodies 
Inhibition of T Cell Mitogenesis by Anti-IL-2.  Given the capacity of anti-IL-2 
antibody to inhibit IL-2-dependent T  lymphoblast growth, it was of interest to 
determine its effect on more complex multicellular responses. As seen in Fig. 4, 
the addition of anti-IL-2 Ig to MLR strongly suppressed T  cell multiplication as 
assessed by [3H]-TdR incorporation, whereas preimmune Ig was without effect. 
The same pattern was observed in cultures exposed to mitogenic stimulation by 
Con A: once again, spleen cell proliferation was markedly inhibited by anti-IL-2 
Ig (50%  reduction of [3H]-TdR  labeling at  50 #g]ml of antibody protein) but 
not by preimmune Ig. The generation of alloreactive CTL on MLR was also 
affected by anti-IL-2 antibody (Fig. 5). 
Effect of Anti-IL-2 on T Cell Helper Activity.  Previous work (7) has shown that 
TABLE  IV 
Specificity of a-IL-2 Immunoabsorption 
Lymphokine  Source of factor 
Fraction tested: 
Start  Unbound  Eiuted 
IL-2*  Con A sup  2.7  0  1.6 
IL-3  *  WEHI-3 sup  0.70  0.65  0 
IFN  t  Con A sup  300  300  0 
IL-1 !  J774 +  LPS sup  7,354  7,127  0 
B cell stimulating factor  ~  Syn MLR sup  4,920  3,750  3 
Cytotoxic factor**  Con A sup  48  32  1 
Supernatants  were  applied  to  a  a-IL-2  lgG  Sepharose  column.  Aliquots of the 
fractions were tested for lymphokines activity. 
• ~;0 Results are expressed respectively as U/ml of IL-2, IL-3, and IFN activity. 
I  s  Results  are  expressed  as  [ H]-TdR  incorporated  during a  4-b  pulse  by  C3H/J 
thymocytes. 
Results are expressed as PFC for individual culture. 
• * Results are expressed as % of 51Cr released in a 4-h lectin-dependent cytotoxic assay. 746  EFFECT  OF  ANTI-IL-2  ON  IMMUNE  RESPONSES 
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FIGURE 4.  Effect  of anti-IL-2 on proliferation of mixed leukocyte reaction. 1 x  106 spleen 
cells/ml from C57BI/6 mice were mixed with 1.5 x  106 irradiated BALB/c spleen cells/ml 
(1,000 rad), and  100 t*l of the resulting cell suspension were plated in microtest wells. Six 
replicate MLC were conducted containing varying concentrations of either anti-IL-2 (O) or 
preimmune IgG (O). After 4 d, cultures were pulsed for 4 h with [3H]-TdR and the incorpo- 
ration into DNA was determined. 
purified  IL-2  could promote antibody production  in  cultures  of nude  mouse 
spleen cells. The availability of specific antibody enabled us to test whether IL-2 
was  actually  produced  and  required  under  ordinary  conditions  of assay  for 
antibody synthesis in culture. The addition of antibody significantly reduced the 
plaque-forming titer of spleen cultures exposed to SRBC (Fig. 6). The inhibitory 
action of antibody was equally pronounced (70-85%  reduction in plaque num- 
ber) when the antibodies were added together with SRBC, at time 0 or after two 
days of culture (Fig. 6).  When antibody was added to the cultures for the first 
2 d  and then removed,  there  was subsequent  full recovery of plaque-forming 
activity. As expected, the effect of antibody could also be reversed by addition 
of excess IL-2, and preimmune Ig was inert. 
Effect of Anti-IL-2  In  Vivo.  In  view of the  preceding  results,  that anti-IL-2 
specifically affect IL-2, and not other cytokines, and could block the  MLR,  it 
seems  desirable  to  explore  the  consequences  of  injected  antibodies  in  situ, 
particularly since this might produce evidence about a  possible role for IL-2 in 
modulating T  cell functions in vivo. We used an immunization protocol known 
to generate alloreactive CTL in  vivo (13),  in the course of which some of the 
mice received daily injections of anti-IL-2 Ig, while control mice were injected 
either with saline or with preimmune Ig. Control determinations were performed 
to assess the level of circulating anti-IL-2 and stable titers of circulating activity GRANELLI-PIPERNO  ET  AL.  747 
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FIGURE 5.  Effect of anti-lL-2  on  mixed leukocyte reaction:generation  of CTL.  1  x  108 
spleen cells/ml from C57B1/6 mice were mixed with 1.5 X 106 irradiated BALB/c spleen cells/ 
ml (1,000 tad) and  1 ml of cell suspension was plated in  16mm macro wells and anti-IL-2 or 
preimmune IgG added  at the indicated concentration.  After 5  d  viable effector cells were 
counted and tested for lytic reactivity against S]Cr_labeled  P815 tumor target cells. White bar, 
E/T 1:50; black bar, E/T 1:15. 
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FIGURE 6.  Effect ofanti-IL-2 on T  helper activity. IgG were added to the cultures on day 0 
or day 2. Helper activity was measured with PFC assay on day 5. 748  EFFECT  OF  ANTI-IL-2  ON  IMMUNE  RESPONSES 
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FIGURE 7.  Ability of IL-2 antibody to inhibit cytotoxic T  cell formation in vivo. BALB/c 
mice were inoculated in the right hind foot pad with 3  x  106 C57B1/6 spleen cells.  Three 
groups  of  18  mice each  were either  left uninjected (O),  or were given daily  intravenous 
injections of anti-lL-2 Ig (0.4 mg/ml) (0) or preimmune Ig (0.4 mg/ml) (×). At the indicated 
times lymph node cells from the three groups of animals (6 each) were tested for lytic activity 
51  against  Cr-labeled EL-4 target  in a  4-h cytotoxicity assay.  Lymph nodes draining control 
footpads which were not inoculated with antigen gave no detectable cytotoxic response (<10 s's 
C.U/node). Experiments were repeated 5 times with no significant difference in the results. 
were observed throughout the course of the experiments.  As seen in  Fig.  7, 
lymph node  cells  from  mice  injected  with  anti-IL-2  Ig  showed a  significant 
reduction of specific CTL responses to allogeneic cells compared with lymphoid 
cells from mice that were injected with saline or with preimmune antibody. The 
cytolytic activity mediated by the lymph node cells was specific for the immunized 
aliogeneic cell type, as shown by the fact that inappropriate target cells were not 
lysed. These results strongly implicate IL-2 function during specific cytotoxic T 
cell responses in situ. 
Discussion 
Our results show that the anti-IL-2 antibodies that we have raised in rabbits 
are potentially useful reagents both for isolating mouse IL-2 and for probing the 
functions of this molecule in immune phenomena in vivo and in vitro. 
The antibodies were raised in response to injection of highly purified antigen; 
they are highly specific and may well even be monospecific, but we have not 
rigorously established  this.  The  elution  of three  bands  of protein  from  the GRANELLI-PIPERNO  ET  AL.  749 
immunoaffinity column might cast some doubt on the monospecificity of the Ig, 
but nonspecific absorption of protein to immunoaffinity columns is a well-known 
phenomenon;  furthermore,  the  presence  of IL'2  sequences in  the  apparent 
contaminants have not yet been excluded, and additional experiments are re- 
quired  to  characterize antibody  specificity in  greater detail.  In  spite  of this 
uncertainty, it is clear that the antibodies effectively remove all detectable IL-2 
activity from solution and precipitate a protein whose migration on SDS-PAGE 
is indistinguishable from that of authentic IL-2; further, whatever the limitations 
of their specificity, the antibodies do not interact with the other lymphokines 
such as IL-1, IL-3, 3,-IFN, or B cell stimulating factor(s) or cytotoxic differentia- 
tion factor(s). 
The anti-IL-2 antisera and the Ig purified from them inhibited a  variety of 
immune responses.  These included antigen- and lectin-stimulated T  cell mito- 
genesis, IL-2-dependent lymphoblast proliferation, cytotoxic lymphocyte gener- 
ation in culture, and T  cell helper function in an assay for antibody production 
in culture. In addition, the antibodies reduced the development of alloreactive 
cytotoxic cells in  vivo;  this  finding is,  so far as we are aware, the first direct 
evidence that endogenous  IL-2 may be important for cytotoxic T cell development 
in  vivo.  Since  this  and  other  responses  occur only  in  mixtures  of cells and 
relatively complex media, the availability of anti-IL-2 should facilitate the further 
dissection of the cellular and hormonal pathways that mediate these reactions 
both in vivo and in vitro. The antibodies are therefore likely to be useful as a 
mechanistically specific immunosuppressive agent in experimental contexts in- 
volving a  wide range of immune phenomena. They should also be of value in 
other contexts where tests for IL-2 are needed; these include studies of biosyn- 
thesis of IL-2, and the molecular cloning of its cDNA. 
Summary 
Antibodies to highly purified mouse interleukin 2 (IL-2) were raised in rabbits; 
a  1:500 dilution of antiserum completely blocked the in vitro mitogenic effect 
of 10 -9 M  IL-2.  The antisera functioned effectively to immunoprecipitate bio- 
synthetically labeled IL-2 and the purified immunoglobulins were useful in the 
construction of affinity columns for the adsorption and one-step immunopurifi- 
cation  of IL-2.  The  antibodies  were apparently specific for  IL-2  among the 
lymphokines, they did not block the biological effects of IL-1,  IL-3, "r-IFN, B 
cell stimulating factor(s), and cytotoxic T  cell differentiation factor(s). 
When anti-IL-2 was added to the in vitro reactions, it blocked mixed leukocyte 
reactions (MLR) and associated lymphocyte proliferation, the in vitro generation 
of cytotoxic T  cells, and antibody formation as assessed by erythrocyte-specific 
plaque-forming cells (PFC). 
When injected into mice, anti-IL-2 antibodies also reduced the formation of 
cytotoxic lymphocytes in response to allogeneic cells, suggesting that endogenous 
IL-2 participates in such reactions in vivo. 
Taken together, the results indicate that these IL-2 antibodies will be useful 
adjuncts in the analysis of immune response both in vivo and in vitro. 
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